Collective and Individual Assessment of the Risk of Death from COVID-19 for the Elderly, 2020–2022-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Collective and Individual Assessment of the Risk of Death from COVID-19 for the Elderly, 2020–2022

Published:2023 Issue:18 Volume:5 Page:407-412
ISSN:2096-7071
Container-title:China CDC Weekly
language:en
Short-container-title:

Author:

Zhang Chaobao, ,Wang Hongzhi,Wen Zilu,Bao Zhijun,Li Xiangqi, , ,

Publisher

Chinese Center for Disease Control and Prevention

Subject

Public Health, Environmental and Occupational Health,Infectious Diseases,Epidemiology

Link

https://weekly.chinacdc.cn/en/article/pdf/preview/10.46234/ccdcw2023.077

Reference11 articles.

1. Yan HH, Ding YD, Guo WB. Epidemiological, radiographical, and laboratorial characteristics of Chinese asymptomatic cases with COVID-19: a systematic review and meta-analysis. Front Public Health 2022;10:808471. http://dx.doi.org/10.3389/fpubh.2022.808471.

2. Zhang CB, Wang HZ, Wen ZL, Gu MJ, Liu LY, Li XQ. Asymptomatic transmissibility calls for implementing a Zero-COVID strategy to end the current global crisis. Front Cell Infect Microbiol 2022;12:836409. http://dx.doi.org/10.3389/fcimb.2022.836409.

3. Elzein F, Ibrahim A, Alshahrani F, Mahrous M, Murshid E, Aldhehyan T, et al. Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature. J Infect Public Health 2021;14(4):474 − 7. http://dx.doi.org/10.1016/j.jiph.2021.01.002.

4. Zhang YP, Luo W, Li Q, Wang XJ, Chen J, Song QF, et al. Risk factors for death among the first 80 543 coronavirus disease 2019 (COVID-19) cases in China: relationships between age, underlying disease, case severity, and region. Clin Infect Dis 2022;74(4):630 − 8. http://dx.doi.org/10.1093/cid/ciab493.

5. Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 2021;398(10316):2093 − 100. http://dx.doi.org/10.1016/S0140-6736(21)02249-2.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcopenia, sarcopenic obesity and the clinical outcome of the older inpatients with COVID-19 infection: a prospective observational study;BMC Geriatrics;2024-07-04

2. Morphological analysis for two types of viral particles in vacuoles of SARS-CoV-2-infected cells;Medical Molecular Morphology;2024-02-23

3. Deciphering GABBR1-centered drug targets to fight viral infection with preexisting diabetes;Acta Biochimica et Biophysica Sinica;2023-11-15

4. Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty;Emerging Microbes & Infections;2023-08-30

5. Evaluation of the Knowledge and Attitude of COVID-19 Vaccines Among Pilgrims;Archives of Pharmacy Practice;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3